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Microassay procedures for cAMP-dependent protein 
kinase and phosphorylase were developed which de-
tected these activities in less than 25 p.g of frozen-dri ed 
epidermis from a punch biopsy of skin without homog-
enization. Using these procedures, the activation of 
cAMP-dependent protein kinase and phosphorylase by 
fJ-adrenergic stimulation in mouse skin was studied in 
vivo. Cyclic AMP-dependent protein kinase was stimu-
lated by isoproterenol and inhibited by propranolol. Iso-
proterenol stimulation also activated phosphorylase a in 
mouse skin. In normal epidermis and uninvolved and 
involved epidermis from psoriatic patients no significant 
differences were found in the activities of cAMP-depen-
dent kinase and phosphorylase a. In all experiments we 
observed that the unstimulated activity ratios of phos-
phorylase a/total phosphorylase were around 20-30%; 
these values were much lower than those hitherto re-
ported and show a preponderance of phosphorylase b 
rather than a. We suggest that in previous reports where 
phosphorylase a domination was found, phosphorylase 
b to a activation occurred during homogenization. The 
data also suggest that in the steady state no obvious 
defect in basic activities of cAMP-dependent protein ki-
nase and phpsphorylase is observed in psoriatic skin. 
A method by which various enzyme and biochemical com-
ponents can be measured in microgram samples of freeze-dried 
microdissected tissue has already been established [1,2). In the 
skin, adenosine 3',5'-monophosphate (cAMP) , cAMP-depen-
dent protein kinase and phosphorylase have been demonstrated 
and their activities were measured using skin homogenates 
[3-7). Skin homogenates are probably not suitable for the study 
of the in vivo state of these enzymes, because the activit ies 
change quickly in response to the endogenous cAMP level 
which rises rapidly during manipulation of the samples such as 
anesthesia, resection and homogenization [8). 
In order to assess the role of ,a-adrenergic stimulation in vivo, 
microassay procedures for cAMP-dependent protein kinase and 
phosphorylase were developed, and applied to biopsies from 
normal and psoriatic human skin and also from skin of mice 
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Abbreviations: 
A TP: adenosine 5' -triphospha te 
cAMP: adenosine 3',5' -monophosphate 
EGTA: N,N'-tetra-acetic acid 
FMN: flavin mononucleotide 
IBM X: 3-isobutyl-1-methyl-xanthine 
NAD: nicotinamide adenine dinucleotide 
NADP: nicotinamide adenine dinucleotide phosphate 
which were treated with ,a-adrenergic agonist and antagonist 
intracardially. 
MATERIALS AND METHODS 
Histone II-AS, ethyLeneglycol-bis- (,B-aminoethyL ether) N ,N ' -tetra-
acetic ac id (EGTA), MgCI2, NaF, adenosine 5'-triphospbate (ATP) , 
cAMP, glucose-6-phosphate dehydrogenape, phosphoglucomutase and 
luciferase (A. Fischeri) were obtained fTom Sigma Chemical Co. Nico-
tinamide adenine dinucleotide (NAD), nicotinamide adenine dinucleo-
tide phosphate (NADP) and flavin mononucleotide (FMN) were ob-
tained from Calbiochem. 3-isobutyl-1-methyL-xanthine (IBMX) was 
from Aldrich Chemical Co. [y"tp]ATP was purchased from New Eng-
land Nuclear. Isoproterenol and propranoloL were produ cts of Winthrop 
and Ayerst Laboratory, respectively. Myristyl a Ldehyde was purcha ed 
from Pfaltz & Bauer, Inc. N.Y. 
Sample Preparation 
BALB/c mice 7-10 weeks old were anesthesized by Nembuta l (30 
mg/ kg) and injected intra-cardialLy (a fter thoracotomy) with 100 ILl 
each of isoproterenol (2 j.<g/ml saline) or the combina tion of the same 
amount of isoproterenol and a 100-fold excess of propranoLoL in saline. 
Control mice were injected with lOOI.tI each of physiological saLine. Two 
minutes after the injection, a 5 x 5 rum size skin sample from femora l 
region was excised and fTozen within a seco'nd between 2 plates of Dry 
Ice. Frozen samples were cut at 20 /-1m in thickness with a cryostat and 
Lyophylized at -30°C. Then, epidermis was dissected from dermis by 
free-hand under a stereo-microscope. 
Shave biopsies [9] from normal human and pig skin , and both 
involved and uninvolved skin of psoriatic patients were obtained afte r 
freezing the skin with liquid nitrogen spray. These sampLes were cut 
and freeze-dried in the same way as mouse skin. Both mouse and 
human epidermal samples were microdissecLed free from dermis and 
skin appendages [10], weighed with a quartz fib er balance [1], and used 
for the foUowing enzyme assays. 
Cyclic AMP-Dep en.dent Protein K in.ase Assay 
The assay system was scaled down from our origina l system [II). 
The reagent mix ture consisted of histone II-AS 20 Itg/ 10 /-IL, potassium 
phosphate buffer pH 6.8 30 mM, NaF 10 mM, Mg-acetate 10 mM , EGTA 
0.25 mM, IBMX 0.1 mM , ATP 20 ILM (conta ining abou t 0.2 /-1C of [y"tP] 
ATP / 10 /-I I) and cAMP 5 f..tM. T en microliLers of the reagenL mixture 
with or without cAMP was added to 25 ILg of dry epidermis previously 
put into a homemade test tube measuring 4 x 25 mm in size. After 10 
min incubation at 30°C, the reaction was stopped by addi t ion of glacia l 
acetic ac id to a finaL concentration of 30%. Fifteen microLiters of Lhe 
reaction mixture were spotted on 1 X 2 cm phosphocellulose paper 
(Whatman P 81) [12], and washed in tap water with gentle stirring for 
75 min, dehydrated in acetone, dried, and counted with Packaxd scin-
tilla tion counter. 
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Cyclic AMP Assay 
Cyclic AMP was assayed by a microassay method [2] using reagenLs 
from CoUaborative Research, Inc. Ten micrograms of dl'y epidermis 
were used in th is assay. 
Phosphory lase Assay 
The assay method for phosphorylase a was essentia lly based on 
those of Cori, Cori, and Green [13). The reagent mixture contains Tri5 
buffer pH 7.2 50 mM, NADP 0.2 mM, glycogen 15 mM, H2PO" 1 M, 
MgCb 1) mM , EDTA 0.5 mM , bovine serum albumin 5%, glu cose-6-
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phosphate dehyd.rogenase (Sigma) 0.2 unit and phosphoglucomu tase 
(Sigma) 0.95 uni t. For total phosphorylase assay 1 mM 5'AMP was also 
added. Five microliters of the reagent mixture was added to 10 fl.g of 
epidermis in the micro-test tube. After 10 min incubation at 37 °C, 
samples were transferred to an ice cold water bath. The reaction 
product NADPH was measured by a photokinetic microassay of Brolin 
et al [14] with slight modification. In short, the reaction mixtures 
stopped in cold water were diluted wit h 100 fl.l each of cold water . 
Twenty microliters each of the mixture was injected into a light-yielding 
solution which consisted of Na+-K+ phosphate buffer, pH 6.8, (100 
mM), 2-mercaptoethanol (2 fl. l) , luciferase (A. Fischeri, 10 mg), FMN (2 
fl.g) , a nd saturated myristyl aldehyde in methanol (5 fl. l) in a total 
volume of 200 fl.l. The resulting bioluminescence was measw·ed in 
Chem-Glow Photometer (American Instrument Co., Md.) attached 
with Shimazu recorder. 
RESULTS 
Figure 1 shows the time course of protein kinase activity of 
the frozen -dried epidermis in the presence or absence of cAMP. 
The activity of microdissected epidermis was essentially linear 
with incubation time and was similru· to that of epidermal 
homogenates [11]. The activity ratio became stable after 5 min 
of incubation and, therefore, 10 min incubation was routinely 
used. The enzyme activities in various amounts of tissue are 
shown in Fig 2. The ratio was stable at all tissue levels. The 
data again supports the validity of the use of the frozen -dried 
epidermis for the enzyme assays. From these results a lO-min 
incubation time and 25 p.g of epidermis were used in routine 
assays. The time course and optimal tissue amount for the 
phosphorylase assay were also studied (data not shown), and 
10 min incubation with 10 p.g tissue were chosen as a routine 
assay condition. 
Table I summarizes the effects of intra-cardiac administration 
of ,B-adrenergic agonist isoproterenol on the intraepidermal 
cAMP levels and activity ratio of protein kinase and phosphor-
ylase. The ,B-agonist given in vivo clearly increases the cAMP 
levels and activates both cAMP-dependent protein kinase and 
phosphorylase. It is noted that control 2 group (saline injec-
tions) shows the activation of the cAMP system in epidermis as 
compared with the control 1 group, which had no injection (nor 
thoracotomy) at all. This difference may have been due to the 
effects of thoracotomy just prior to the intra-cardiac injection 
of saline. The simultaneous injection of the ,B-adrenergic agonist 
and antagonist just yielded the same cAMP levels and activity 
ratio as the saline injection had caused. The activity ratios of 
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FIG 1. The time course of cAMP-dependent protein kinase assay. 
Twenty-five micrograms dry weight pig epidermis was used for each 
assay. Activity without cAMP (0-0), with cAMP (e----e), cAMP-
dependent protein kinase activity ratio (x----x). 
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protein kinase and phosphorylase in femoral muscle were also 
assayed with the same animals. Both ratios were also activated 
within 60 seconds (data not shown). 
Table II summarizes the basal (unstinlUlated) levels of the 
activity ratio of protein kinase and phosphorylase in human 
epidermis. Both activity ratios ru·e virtually identical in epider-
mis from normal (healthy) skin, uninvolved (normal appearing) 
and involved (diseased) skin of psoriasis patients. 
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FIG 2. Effect of tissue (pig epidermis) amount on cAMP-dependent 
protein kinase activity and activity rat io. Incubation t ime was 10 min. 
Activity without cAMP (0--0), with cAMP ( _____ ), cAMP-de-
pendent protein kinase activity ra t io (x----x) . n = 5. 
TABLE I. cAMP level, protein llinase activity, and phosphorylase 
activity ratio in mouse shin 
cAMP pmol/mg Protein kinase activ- Phosphorylase ratio ity ratio (%) (%) (-5 'AMPI dry wt. (-cA MP / +cAMP) + 5'AMP) 
Control 1" 0.23 ± 0.Ql7 48.3 ± 1.93 20.4 ± 0.86 
(0.17 - 0.26) (43.7 - 53.0) (18.6 - 23.4) 
Control 2" 0.51 ± 0.058 64.8 ± 2.09 24.6 ± 1.51 
(0.36 - 0.68) (60.0 - 70.1) (19.1 - 26.1) 
Isoprot." 1.05 ± 0.050 86.9 ± 3.82 51.0 ± 2.34 
(0.86 - 1.15) (73.5 - 95.7) (41.9 - 55.1) 
Isoprot. + 0.57 ± 0.041 63.0 ± 1:75 25.9 ± 1.34 
Propra. (0.45 - 0.68) (57.0 - 67.4) (22.1 - 28.2) 
" Control 1 = no injection, control 2 = saline injection. 
" Isoprot. = isoproterenol , Isoprot. + Propra. = simultaneous injec-
tion of isoproterenol and propranolol. AU injections were done via an 
intracardiac rou te. For deta ils see Methods. (n = 5 animals, triplicate 
to sextuplicate determinations each) mean values ± SE are shown with 
ranges of variation in parentheses. I-Tests between control 2 and 
isoproterenol groups show p < 0.001 cAMP and phosphorylase ratio, 
and p < 0.05 for protein kinase activity rat.io. 
TABLE II. The a.ctivity ratio of protein hinase a.nd phosphorylase ill 
human epidermis 
Normal human epidermis 
Psoriatic epidermis 
Uninvolved 
Involved 
Protein kinase activity 
ratio (%) (-cA MPI 
+cAMP) 
54.8 ± 5.60 
(32.0 - ' 70.8) 
60.5 ± 3.21 
(56.2 - 70.2) 
56.3 ± 4.10 
(44.0 - 70.7) 
Phosphorylase ratio 
(%) (-5'AMPI 
+5'AMP) 
31.0 ± 1.95 
(25.1 - 38.0) 
29.0 ± 2.35 
(23.3 - 38.6) 
32.2 ± 1.74 
(26.4 - 38.2) 
" Average values of 6 subjects or patients ± SE are shown. Each 
value is an average of triplicate to sextuplicate determinations. The 
extents of va.riation are shown in parentheses. All values are statistically 
not significant (p ~ 0.5). 
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DISCUSSION 
The micro assay procedure is very valuable for studying var-
ious biochemical parameters of the skin, because it enables 
analyses in the histologically defined components of skin in 
health and disease. We established a micro assay procedure for 
cAMP-dependent protein kinase requiring 25 JLg of dissected 
epidermis. Using a 4-mm punch or shave biopsy after quick 
freezing anesthesia, we can measure physiological or pharma-
cologically treated epidermal levels of cf\M!:' -dependent protein 
kinase activity. With this method, combined with the micro as-
say procedures for cAMP [2,9] and phosphorylase, we have 
demonstrated that the effects of ,B-adrenergic stimulation on 
the cAMP system in epidermis are not different from the 
responses by other tissues such as liver and muscle. 
After the ,B-adrenergic stimulation, the activity ratio of 
cAMP-dependent protein kinase increased from 50% to 85%. 
Previously, we have observed full activation (90 - 100%) of the 
enzyme in in vitro incubation of epidermal slices for 30 seconds 
with the same concentration of epinephrine [11]. This difference 
might have been due to inadequate concentrations reaching the 
epidermis in vivo. However, failure of higher drug concentra-
tions to further activate suggests that this limited activation is 
a real in vivo phenomenon. The data are consistent with our 
previous report [15] that the in vivo intradermal injection of 
epinephrine caused only moderate increases in cAMP levels as 
compared with marked increases observed with the in vitro 
(epidermal slice) system . 
It is noteworthy that the ratio of phosphorylase activities in 
the absence and presence of adenylic acid was in the range of 
20 - 30%, when the frozen-dried epidermis was used as samples. 
With homogenates of epidermis as samples, t he ratio has been 
reported to be over 60% (3 - 7). Our new data thus suggest that 
in normally unstimulated epidermis phosphorylase b rather 
than phosphorylase a is the dominant type. All previous reports 
on phosphorylase a being dominant form in skin might have 
been due to the lengthy manipulation of skin. 
Adenyl cyclase activation is so sensitive that intradermal 
injections of any kind (even saline) result in a rise in cyclic 
AMP which then activates cAMP dependent protein kinase 
and phosphorylase. Only by using systemic treatment (intra-
cardiac) could we show true activation occurring in the epider-
mis and even here some ,B-adrenergic stimulation occurred 
during the process of giving intracardiac saline. 
In our study, cyclic AMP-dl"pendent protein kinase and phos-
phorylase activities in uninvolved and involved epidermis from 
psoriatic patients did not show significant change in comparison 
with normal human epidermis. This appears to contradict the 
Vol. 79, No.3 
results by Mier and Hurk [7], who found a reduced phosphor-
ylase activation in the lesion as compared to normal or unin-
volved skin of psoriasis patients. However, this apparent dis-
crepancy can be explained by the marked differences in the 
ratio of phosphorylase a/total phosphorylase activities (60% vs 
25%, c.f. above paragraph). In their works, keratome slices were 
removed without in vivo freezing and then homogenized to 
obtain crude enzyme source. There is little doubt based on our 
protein kinase studies [11] that these manipulations would 
cause adenyl cyclase, protein kinase, and phosphorylase b to a 
activation. Thus the apparent discrepancy could be explained 
if the lesion did not react to ischemia as much as the normal 
appearing skin did. 
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